{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T05:15:10Z","timestamp":1779167710132,"version":"3.51.4"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Immunology"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/j.molimm.2020.01.006","type":"journal-article","created":{"date-parts":[[2020,1,18]],"date-time":"2020-01-18T11:45:51Z","timestamp":1579347951000},"page":"35-45","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"special_numbering":"C","title":["EZH2 inhibitors restore epigenetically silenced CD58 expression in B-cell lymphomas"],"prefix":"10.1016","volume":"119","author":[{"given":"Yasuyuki","family":"Otsuka","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Momoko","family":"Nishikori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Arima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiyotaka","family":"Izumi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshio","family":"Kitawaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masakatsu","family":"Hishizawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akifumi","family":"Takaori-Kondo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"14","key":"10.1016\/j.molimm.2020.01.006_bib0005","first-page":"3343","article-title":"Differential expression of cell adhesion molecules CD54\/CD11a and CD58\/CD2 by human melanoma cells and functional role in their interaction with cytotoxic cells","volume":"53","author":"Altomonte","year":"1993","journal-title":"Cancer Res."},{"issue":"4","key":"10.1016\/j.molimm.2020.01.006_bib0010","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1056\/NEJMoa1411087","article-title":"PD-1 blockade with nivolumab in relapsed or refractory Hodgkin\u2019s lymphoma","volume":"372","author":"Ansell","year":"2015","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.molimm.2020.01.006_bib0015","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1200\/JCO.18.00766","article-title":"Nivolumab for Relapsed\/Refractory diffuse large B-Cell lymphoma in patients ineligible for or having failed autologous transplantation: a single-arm, phase II study","volume":"37","author":"Ansell","year":"2019","journal-title":"J. Clin. Oncol."},{"issue":"14","key":"10.1016\/j.molimm.2020.01.006_bib0020","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1200\/JCO.2017.76.0793","article-title":"Nivolumab for Relapsed\/Refractory classic hodgkin lymphoma after failure of autologous hematopoietic cell transplantation: extended follow-up of the multicohort single-arm phase II CheckMate 205 trial","volume":"36","author":"Armand","year":"2018","journal-title":"J. Clin. Oncol."},{"issue":"5","key":"10.1016\/j.molimm.2020.01.006_bib0025","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.ccr.2013.04.011","article-title":"EZH2 is required for germinal center formation and somatic EZH2 mutations promote lymphoid transformation","volume":"23","author":"Beguelin","year":"2013","journal-title":"Cancer Cell"},{"issue":"11","key":"10.1016\/j.molimm.2020.01.006_bib0030","doi-asserted-by":"crossref","first-page":"3939","DOI":"10.4049\/jimmunol.136.11.3939","article-title":"Induction and blocking of cytolysis in CD2+, CD3- NK and CD2+, CD3+ cytotoxic T lymphocytes via CD2 50 KD sheep erythrocyte receptor","volume":"136","author":"Bolhuis","year":"1986","journal-title":"J. Immunol."},{"issue":"11","key":"10.1016\/j.molimm.2020.01.006_bib0035","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1038\/nrc2736","article-title":"Polycomb group proteins: navigators of lineage pathways led astray in cancer","volume":"9","author":"Bracken","year":"2009","journal-title":"Nat. Rev. Cancer"},{"issue":"12","key":"10.1016\/j.molimm.2020.01.006_bib0040","doi-asserted-by":"crossref","first-page":"5009","DOI":"10.1172\/JCI70626","article-title":"Germinal center dysregulation by histone methyltransferase EZH2 promotes lymphomagenesis","volume":"123","author":"Caganova","year":"2013","journal-title":"J. Clin. Invest."},{"issue":"50","key":"10.1016\/j.molimm.2020.01.006_bib0045","doi-asserted-by":"crossref","first-page":"83294","DOI":"10.18632\/oncotarget.13065","article-title":"Mutations or copy number losses of CD58 and TP53 genes in diffuse large B cell lymphoma are independent unfavorable prognostic factors","volume":"7","author":"Cao","year":"2016","journal-title":"Oncotarget"},{"issue":"22","key":"10.1016\/j.molimm.2020.01.006_bib0050","doi-asserted-by":"crossref","first-page":"2420","DOI":"10.1182\/blood-2017-03-770719","article-title":"Topological analysis reveals a PD-L1-associated microenvironmental niche for Reed-Sternberg cells in Hodgkin lymphoma","volume":"130","author":"Carey","year":"2017","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.molimm.2020.01.006_bib0055","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.ccr.2011.11.006","article-title":"Combined genetic inactivation of \u03b22-Microglobulin and CD58 reveals frequent escape from immune recognition in diffuse large B cell lymphoma","volume":"20","author":"Challa-Malladi","year":"2011","journal-title":"Cancer Cell"},{"issue":"5","key":"10.1016\/j.molimm.2020.01.006_bib0060","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/s41591-018-0016-8","article-title":"Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes","volume":"24","author":"Chapuy","year":"2018","journal-title":"Nat. Med."},{"issue":"19","key":"10.1016\/j.molimm.2020.01.006_bib0065","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1200\/JCO.2016.72.1316","article-title":"Phase II study of the efficacy and safety of Pembrolizumab for Relapsed\/Refractory classic hodgkin lymphoma","volume":"35","author":"Chen","year":"2017","journal-title":"J. Clin. Oncol."},{"issue":"12","key":"10.1016\/j.molimm.2020.01.006_bib0070","doi-asserted-by":"crossref","first-page":"2919","DOI":"10.1158\/1078-0432.CCR-15-2305","article-title":"Next-generation sequencing in diffuse large B-Cell lymphoma highlights molecular divergence and therapeutic opportunities: a LYSA study","volume":"22","author":"Dubois","year":"2016","journal-title":"Clin. Cancer Res."},{"issue":"5","key":"10.1016\/j.molimm.2020.01.006_bib0075","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1002\/1097-0142(197811)42:5<2379::AID-CNCR2820420539>3.0.CO;2-4","article-title":"Biology of the human malignant lymphomas. IV. Functional characterization of ten diffuse histiocytic lymphoma cell lines","volume":"42","author":"Epstein","year":"1978","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.molimm.2020.01.006_bib0080","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1038\/86318","article-title":"Gene regulation mediated by calcium signals in T lymphocytes","volume":"2","author":"Feske","year":"2001","journal-title":"Nat. Immunol."},{"issue":"5425","key":"10.1016\/j.molimm.2020.01.006_bib0085","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1126\/science.285.5425.221","article-title":"The immunological synapse: a molecular machine controlling T cell activation","volume":"285","author":"Grakoui","year":"1999","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.molimm.2020.01.006_bib0090","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1006\/jsre.1996.0021","article-title":"Role of LFA-3, ICAM-1, and MHC class I on the sensitivity of human tumor cells to LAK cells","volume":"60","author":"Gwin","year":"1996","journal-title":"J. Surg. Res."},{"issue":"5","key":"10.1016\/j.molimm.2020.01.006_bib0095","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/S1470-2045(18)30145-1","article-title":"Tazemetostat, an EZH2 inhibitor, in relapsed or refractory B-cell non-Hodgkin lymphoma and advanced solid tumours: a first-in-human, open-label, phase 1 study","volume":"19","author":"Italiano","year":"2018","journal-title":"Lancet Oncol."},{"issue":"1","key":"10.1016\/j.molimm.2020.01.006_bib0100","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/sj.leu.2400555","article-title":"Potential role for concurrent abnormalities of the cyclin D1, p16CDKN2 and p15CDKN2B genes in certain B cell non-Hodgkin\u2019s lymphomas. Functional studies in a cell line (Granta 519)","volume":"11","author":"Jadayel","year":"1997","journal-title":"Leukemia"},{"issue":"7","key":"10.1016\/j.molimm.2020.01.006_bib0105","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.4049\/jimmunol.148.7.2023","article-title":"CD2\/LFA-3 ligation induces phospholipase-C gamma 1 tyrosine phosphorylation and regulates CD3 signaling","volume":"148","author":"Kanner","year":"1992","journal-title":"J. Immunol."},{"issue":"3","key":"10.1016\/j.molimm.2020.01.006_bib0110","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1038\/leu.2017.251","article-title":"Integrating genomic alterations in diffuse large B-cell lymphoma identifies new relevant pathways and potential therapeutic targets","volume":"32","author":"Karube","year":"2018","journal-title":"Leukemia"},{"issue":"11","key":"10.1016\/j.molimm.2020.01.006_bib0115","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1038\/ng.3415","article-title":"Integrated molecular analysis of adult T cell leukemia\/lymphoma","volume":"47","author":"Kataoka","year":"2015","journal-title":"Nat. Genet."},{"issue":"2","key":"10.1016\/j.molimm.2020.01.006_bib0120","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/nm.4036","article-title":"Targeting EZH2 in cancer","volume":"22","author":"Kim","year":"2016","journal-title":"Nat. Med."},{"issue":"7","key":"10.1016\/j.molimm.2020.01.006_bib0125","first-page":"1300","article-title":"Surface IgM-kappa specificity on a Burkitt lymphoma cell in vivo and in derived culture lines","volume":"28","author":"Klein","year":"1968","journal-title":"Cancer Res."},{"issue":"2","key":"10.1016\/j.molimm.2020.01.006_bib0130","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1038\/nprot.2006.98","article-title":"Chromatin immunoprecipitation and microarray-based analysis of protein location","volume":"1","author":"Lee","year":"2006","journal-title":"Nat. Protoc."},{"issue":"23","key":"10.1016\/j.molimm.2020.01.006_bib0135","doi-asserted-by":"crossref","first-page":"2698","DOI":"10.1200\/JCO.2015.65.9789","article-title":"Nivolumab in patients with relapsed or refractory hematologic malignancy: preliminary results of a phase ib study","volume":"34","author":"Lesokhin","year":"2016","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.molimm.2020.01.006_bib0140","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.leukres.2015.12.015","article-title":"CD38+ CD58- is an independent adverse prognostic factor in paediatric Philadelphia chromosome negative B cell acute lymphoblastic leukaemia patients","volume":"43","author":"Li","year":"2016","journal-title":"Leuk. Res."},{"issue":"5","key":"10.1016\/j.molimm.2020.01.006_bib0145","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s11899-018-0466-6","article-title":"Emerging EZH2 inhibitors and their application in lymphoma","volume":"13","author":"Lue","year":"2018","journal-title":"Curr. Hematol. Malig. Rep."},{"issue":"9","key":"10.1016\/j.molimm.2020.01.006_bib0150","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1111\/j.1349-7006.2003.tb01518.x","article-title":"Comparison of gene expression profiles of lymphoma cell lines from transformed follicular lymphoma, Burkitt\u2019s lymphoma and de novo diffuse large B-cell lymphoma","volume":"94","author":"Maesako","year":"2003","journal-title":"Cancer Sci."},{"issue":"6222","key":"10.1016\/j.molimm.2020.01.006_bib0155","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1038\/339312a0","article-title":"CD2-mediated adhesion facilitates T lymphocyte antigen recognition function","volume":"339","author":"Moingeon","year":"1989","journal-title":"Nature"},{"issue":"12","key":"10.1016\/j.molimm.2020.01.006_bib0160","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1038\/gt.2008.17","article-title":"Development of an enhanced B-specific lentiviral vector expressing BTK: a tool for gene therapy of XLA","volume":"15","author":"Moreau","year":"2008","journal-title":"Gene Ther."},{"issue":"2","key":"10.1016\/j.molimm.2020.01.006_bib0165","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/ng.518","article-title":"Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center origin","volume":"42","author":"Morin","year":"2010","journal-title":"Nat. Genet."},{"issue":"4","key":"10.1016\/j.molimm.2020.01.006_bib0170","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1620\/tjem.156.319","article-title":"Establishment and characterization of an Epstein-Barr virus negative B-cell lymphoma cell line and successful heterotransplantation","volume":"156","author":"Nozawa","year":"1988","journal-title":"Tohoku J. Exp. Med."},{"issue":"2","key":"10.1016\/j.molimm.2020.01.006_bib0175","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/ng.2873","article-title":"Recurrent mutations in epigenetic regulators, RHOA and FYN kinase in peripheral T cell lymphomas","volume":"46","author":"Palomero","year":"2014","journal-title":"Nat. Genet."},{"issue":"9","key":"10.1016\/j.molimm.2020.01.006_bib0180","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1038\/ng.892","article-title":"Analysis of the coding genome of diffuse large B-cell lymphoma","volume":"43","author":"Pasqualucci","year":"2011","journal-title":"Nat. Genet."},{"issue":"1","key":"10.1016\/j.molimm.2020.01.006_bib0185","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.celrep.2013.12.027","article-title":"Genetics of follicular lymphoma transformation","volume":"6","author":"Pasqualucci","year":"2014","journal-title":"Cell Rep."},{"issue":"7327","key":"10.1016\/j.molimm.2020.01.006_bib0190","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/S0140-6736(64)92345-1","article-title":"Cytology of burkitt\u2019s tumour (African lymphoma)","volume":"1","author":"Pulvertaft","year":"1964","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.molimm.2020.01.006_bib0195","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.cell.2017.09.027","article-title":"Genetic and functional drivers of diffuse large B cell lymphoma","volume":"171","author":"Reddy","year":"2017","journal-title":"Cell"},{"issue":"12","key":"10.1016\/j.molimm.2020.01.006_bib0200","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1111\/j.1349-7006.2009.01344.x","article-title":"Distinctive cell properties of B cells carrying the BCL2 translocation and their potential roles in the development of lymphoma of germinal center type","volume":"100","author":"Sakai","year":"2009","journal-title":"Cancer Sci."},{"issue":"23","key":"10.1016\/j.molimm.2020.01.006_bib0205","doi-asserted-by":"crossref","first-page":"7489","DOI":"10.1073\/pnas.79.23.7489","article-title":"Three distinct antigens associated with human T-lymphocyte-mediated cytolysis: LFA-1, LFA-2, and LFA-3","volume":"79","author":"Sanchez-Madrid","year":"1982","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"15","key":"10.1016\/j.molimm.2020.01.006_bib0210","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1056\/NEJMoa1801445","article-title":"Genetics and pathogenesis of diffuse large B-Cell lymphoma","volume":"378","author":"Schmitz","year":"2018","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.molimm.2020.01.006_bib0215","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1038\/nbt.1621","article-title":"Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation","volume":"28","author":"Trapnell","year":"2010","journal-title":"Nat. Biotechnol."},{"issue":"24","key":"10.1016\/j.molimm.2020.01.006_bib0220","doi-asserted-by":"crossref","first-page":"5247","DOI":"10.1182\/blood-2010-04-280149","article-title":"EZH2-mediated epigenetic silencing in germinal center B cells contributes to proliferation and lymphomagenesis","volume":"116","author":"Velichutina","year":"2010","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.molimm.2020.01.006_bib0225","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/S0092-8674(00)80790-4","article-title":"Structure of a heterophilic adhesion complex between the human CD2 and CD58 (LFA-3) counterreceptors","volume":"97","author":"Wang","year":"1999","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.molimm.2020.01.006_bib0230","doi-asserted-by":"crossref","first-page":"3220","DOI":"10.1182\/blood-2007-05-085159","article-title":"PD-1-PD-1 ligand interaction contributes to immunosuppressive microenvironment of Hodgkin lymphoma","volume":"111","author":"Yamamoto","year":"2008","journal-title":"Blood"},{"issue":"21","key":"10.1016\/j.molimm.2020.01.006_bib0235","doi-asserted-by":"crossref","first-page":"6129","DOI":"10.1158\/0008-5472.CAN-14-0643","article-title":"Molecular characterization of chronic-type adult T-cell leukemia\/lymphoma","volume":"74","author":"Yoshida","year":"2014","journal-title":"Cancer Res."},{"issue":"4","key":"10.1016\/j.molimm.2020.01.006_bib0240","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/j.celrep.2017.07.007","article-title":"The histone methyltransferase Ezh2 controls mechanisms of adaptive resistance to tumor immunotherapy","volume":"20","author":"Zingg","year":"2017","journal-title":"Cell Rep."}],"container-title":["Molecular Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161589019306431?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161589019306431?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T13:33:02Z","timestamp":1758979982000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161589019306431"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":48,"alternative-id":["S0161589019306431"],"URL":"https:\/\/doi.org\/10.1016\/j.molimm.2020.01.006","relation":{},"ISSN":["0161-5890"],"issn-type":[{"value":"0161-5890","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"EZH2 inhibitors restore epigenetically silenced CD58 expression in B-cell lymphomas","name":"articletitle","label":"Article Title"},{"value":"Molecular Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.molimm.2020.01.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}